0001193125-26-051663.txt : 20260213 0001193125-26-051663.hdr.sgml : 20260213 20260213165022 ACCESSION NUMBER: 0001193125-26-051663 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260213 DATE AS OF CHANGE: 20260213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RAPID MICRO BIOSYSTEMS, INC. CENTRAL INDEX KEY: 0001380106 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 208121647 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92824 FILM NUMBER: 26634099 BUSINESS ADDRESS: STREET 1: 25 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 978-349-3200 MAIL ADDRESS: STREET 1: 25 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: RAPID MICRO BIOSYSTEMS INC DATE OF NAME CHANGE: 20061103 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Endeavour Medtech Growth II LP CENTRAL INDEX KEY: 0001873032 ORGANIZATION NAME: EIN: 981530409 STATE OF INCORPORATION: Y7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: P.O. BOX 656, EAST WING, TRAFALGAR COURT STREET 2: LES BANQUES CITY: ST PETER PORT PROVINCE COUNTRY: Y7 BUSINESS PHONE: 44 1481 749 714 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: P.O. BOX 656, EAST WING, TRAFALGAR COURT STREET 2: LES BANQUES CITY: ST PETER PORT PROVINCE COUNTRY: Y7 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0001873032 XXXXXXXX LIVE 3 Common Stock, par value $0.01 12/31/2025 0001380106 Rapid Micro Biosystems, Inc. 75340L104 25 Hartwell Avenue Lexington MA 02421 Rule 13d-1(c) Endeavour Medtech Growth II LP b Y7 0 2257099 0 2257099 2257099 N 5.7 PN (1) Includes (i) 2,217,190 shares of Class A common stock held by Endeavour Medtech Growth II LP and (ii) 39,909 shares of Class A common stock held by Endeavour Medtech Growth II Parallel LP. (2) Based on 39,823,026 shares of Class A Common Stock of the Issuer outstanding as of October 31, 2025 as reported by the Issuer in the Form 10-Q, filed with the United States Securities and Exchange Commission (the "Commission") on November 7, 2025 (the "Form 10-Q"). Endeavour Medtech Growth II Parallel LP b Y7 0 2257099 0 2257099 2257099 N 5.7 PN (1) Includes (i) 2,217,190 shares of Class A common stock held by Endeavour Medtech Growth II LP and (ii) 39,909 shares of Class A common stock held by Endeavour Medtech Growth II Parallel LP. (2) Based on 39,823,026 shares of Class A Common Stock of the Issuer outstanding as of October 31, 2025 as reported by the Issuer in the Form 10-Q, filed with the United States Securities and Exchange Commission (the "Commission") on November 7, 2025. Endeavour Medtech II GP Limited b Y7 0 2257099 0 2257099 2257099 N 5.7 PN (3) Includes (i) 2,217,190 shares of Class A common stock held by Endeavour Medtech Growth II LP and (ii) 39,909 shares of Class A common stock held by Endeavour Medtech Growth II Parallel LP. (4) Based on 39,823,026 shares of Class A Common Stock of the Issuer outstanding as of October 31, 2025 as reported by the Issuer in the Form 10-Q, filed with the United States Securities and Exchange Commission (the "Commission") on November 7, 2025. Rapid Micro Biosystems, Inc. 25 Hartwell Avenue, Lexington, MA 02421 This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): (i) Endeavour Medtech Growth II LP (ii) Endeavour Medtech Growth II Parallel LP (iii) Endeavour Medtech II GP Limited The address of the principal business and principal office of each of the Reporting Persons is P.O. Box 656, East Wing Trafalgar Court, Les Banques, St Peter Port, Guernsey GY1 3PP Each of (1) Endeavour Medtech Growth II LP, (2) Endeavour Medtech Growth II Parallel LP and (3) Endeavour Medtech II GP Limited is a Guernsey limited partnership. Y Endeavour Medtech Growth II LP 2,217,190 shares of Class A common stock are held of record by Endeavour Medtech Growth II LP ("EMG II"). Endeavour Medtech II GP Limited ("Endeavour GP") is the general partner of EMG II. Endeavour Medtech Growth II Parallel LP 39,909 shares of Class A common stock are held of record by Endeavour Medtech Growth II Parallel LP ("EMG II AFF"). Endeavour GP is the general partner of EMG II AFF. As a result of foregoing, and the relationships described in Item 2(a) of this Schedule 13G, the Reporting Persons may be deemed to share ownership over the reported 2,257,099 shares of Class A common stock, but the filing of this Statement shall not be deemed an admission of such beneficial ownership by any of the Reporting Persons for purposes of Section 13(d) or Section 13(g) or for any other purpose. 5.7% 0 2,257,099 0 2,257,099 N Y Y N Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Endeavour Medtech Growth II LP /s/ Nick Barton 02/13/2026 Endeavour Medtech Growth II Parallel LP /s/ Nick Barton 02/13/2026 Endeavour Medtech II GP Limited /s/ Nick Barton 02/13/2026 Endeavour Medtech Growth II LP is signed for by Endeavour Medtech II GP Limited, its General Partner. Endeavour Medtech Growth II Parallel LP is signed for by Endeavour Medtech II GP Limited, its General Partner..